Company / Gross Margin
Entera Bio Ltd. Gross Margin History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
5.0%
FY2025
5-year range
5.0% / 34.7%
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from 34.7% to 5.0% over the past 3 years.
Based on SEC 10-K filings.
5.0% in FY2025 with a 3-year CAGR of -29.7%.
Declined from 34.7% to 5.0% over the past 3 years.
Gross Margin over time
Growth rates
- 3-Year Change
- -29.7pp
- 5-Year Change
- -
- 10-Year Change
- -
Company context
Key Data Points
- Altman Z-Score -0.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 5.0% | - |
| FY2024 | - | - |
| FY2023 | 24.6% | -29.0% |
| FY2022 | 34.7% | +94.7% |
| FY2021 | 17.8% | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026